In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HIMA workshop

This article was originally published in The Gray Sheet

Executive Summary

Topics for discussion at the eighth annual Health Industry Manufacturers Association device submissions workshop June 27-29 include FDA's allocation of resources for implementation of the FDA Modernization Act, 510(k) and premarket approval application reengineering initiatives, advertising and promotion, labeling and expedited review. Device center staffers scheduled to speak include: Susan Alpert, director of FDA's Office of Device Evaluation, Phil Phillips, ODE deputy director, and Byron Tart, director, promotion and advertising policy staff. The conference is being held at the Omni Shoreham hotel in Washington, D.C. Contact James Blanchard at 202/434-7231 for additional information...

You may also be interested in...



3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.

ACC 2020: Medtronic’s Evolut TAVR Works In Low-Risk Bicuspid Study

Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.

COVID-19 Will Spur Decentralized and Hybrid Trials – Novartis Hails Digital Investment

The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.

UsernamePublicRestriction

Register

MT010155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel